S&P 500   3,845.80 (-0.19%)
DOW   31,066.12 (-0.35%)
QQQ   325.70 (-0.20%)
AAPL   138.27 (+1.02%)
MSFT   227.35 (+1.06%)
FB   275.39 (+0.92%)
GOOGL   1,902.10 (+0.95%)
AMZN   3,295.39 (-0.35%)
TSLA   839.56 (-0.64%)
NVDA   552.11 (-0.47%)
BABA   258.56 (-0.55%)
CGC   33.40 (-0.48%)
GE   11.13 (+0.54%)
MU   82.61 (-2.82%)
AMD   92.47 (+1.03%)
NIO   61.63 (+5.64%)
T   28.84 (+0.03%)
F   11.41 (-1.04%)
ACB   10.49 (-6.09%)
BA   205.10 (-1.11%)
DIS   172.76 (+0.86%)
NFLX   568.47 (-1.96%)
GILD   67.27 (+0.43%)
S&P 500   3,845.80 (-0.19%)
DOW   31,066.12 (-0.35%)
QQQ   325.70 (-0.20%)
AAPL   138.27 (+1.02%)
MSFT   227.35 (+1.06%)
FB   275.39 (+0.92%)
GOOGL   1,902.10 (+0.95%)
AMZN   3,295.39 (-0.35%)
TSLA   839.56 (-0.64%)
NVDA   552.11 (-0.47%)
BABA   258.56 (-0.55%)
CGC   33.40 (-0.48%)
GE   11.13 (+0.54%)
MU   82.61 (-2.82%)
AMD   92.47 (+1.03%)
NIO   61.63 (+5.64%)
T   28.84 (+0.03%)
F   11.41 (-1.04%)
ACB   10.49 (-6.09%)
BA   205.10 (-1.11%)
DIS   172.76 (+0.86%)
NFLX   568.47 (-1.96%)
GILD   67.27 (+0.43%)
S&P 500   3,845.80 (-0.19%)
DOW   31,066.12 (-0.35%)
QQQ   325.70 (-0.20%)
AAPL   138.27 (+1.02%)
MSFT   227.35 (+1.06%)
FB   275.39 (+0.92%)
GOOGL   1,902.10 (+0.95%)
AMZN   3,295.39 (-0.35%)
TSLA   839.56 (-0.64%)
NVDA   552.11 (-0.47%)
BABA   258.56 (-0.55%)
CGC   33.40 (-0.48%)
GE   11.13 (+0.54%)
MU   82.61 (-2.82%)
AMD   92.47 (+1.03%)
NIO   61.63 (+5.64%)
T   28.84 (+0.03%)
F   11.41 (-1.04%)
ACB   10.49 (-6.09%)
BA   205.10 (-1.11%)
DIS   172.76 (+0.86%)
NFLX   568.47 (-1.96%)
GILD   67.27 (+0.43%)
S&P 500   3,845.80 (-0.19%)
DOW   31,066.12 (-0.35%)
QQQ   325.70 (-0.20%)
AAPL   138.27 (+1.02%)
MSFT   227.35 (+1.06%)
FB   275.39 (+0.92%)
GOOGL   1,902.10 (+0.95%)
AMZN   3,295.39 (-0.35%)
TSLA   839.56 (-0.64%)
NVDA   552.11 (-0.47%)
BABA   258.56 (-0.55%)
CGC   33.40 (-0.48%)
GE   11.13 (+0.54%)
MU   82.61 (-2.82%)
AMD   92.47 (+1.03%)
NIO   61.63 (+5.64%)
T   28.84 (+0.03%)
F   11.41 (-1.04%)
ACB   10.49 (-6.09%)
BA   205.10 (-1.11%)
DIS   172.76 (+0.86%)
NFLX   568.47 (-1.96%)
GILD   67.27 (+0.43%)
Log in
OTCMKTS:THERF

Theratechnologies Stock Forecast, Price & News

$2.36
-0.02 (-0.84 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.26
Now: $2.36
$2.39
50-Day Range
$2.09
MA: $2.63
$3.80
52-Week Range
$3.58
Now: $2.36
$7.29
Volume716,874 shs
Average Volume45,196 shs
Market Capitalization$181.61 million
P/E RatioN/A
Dividend YieldN/A
Beta0.58
Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States. The company was founded in 1993 and is headquartered in Montreal, Canada.
Theratechnologies logo

MarketRank

Overall MarketRank

0.48 out of 5 stars

Medical Sector

1551st out of 1,921 stocks

Pharmaceutical Preparations Industry

669th out of 769 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:THERF
Previous SymbolNASDAQ:THER
CUSIPN/A
CIKN/A
Phone514-336-7800
Employees32

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$45.18 million
Cash Flow$0.01 per share
Book Value$0.47 per share

Profitability

Net Income$-4,660,000.00

Miscellaneous

Market Cap$181.61 million
Next Earnings DateN/A
OptionableNot Optionable
$2.36
-0.02 (-0.84 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive THERF News and Ratings via Email

Sign-up to receive the latest news and ratings for THERF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Theratechnologies (OTCMKTS:THERF) Frequently Asked Questions

How has Theratechnologies' stock price been impacted by COVID-19?

Theratechnologies' stock was trading at $2.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, THERF shares have decreased by 18.9% and is now trading at $2.36.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Theratechnologies?

Wall Street analysts have given Theratechnologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Theratechnologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc (OTCMKTS:THERF) posted its earnings results on Thursday, April, 4th. The company reported $0.01 earnings per share for the quarter, meeting analysts' consensus estimates of $0.01. The business earned $15.10 million during the quarter. Theratechnologies had a negative return on equity of 14.31% and a negative net margin of 11.57%.
View Theratechnologies' earnings history
.

Who are some of Theratechnologies' key competitors?

Who are Theratechnologies' key executives?

Theratechnologies' management team includes the following people:
  • Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)
  • Mr. Philippe Dubuc MBA, Sr. VP & CFO (Age 52)
  • Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)
  • Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53)
  • Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)

What is Theratechnologies' stock symbol?

Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF."

How do I buy shares of Theratechnologies?

Shares of THERF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Theratechnologies' stock price today?

One share of THERF stock can currently be purchased for approximately $2.36.

How big of a company is Theratechnologies?

Theratechnologies has a market capitalization of $181.61 million and generates $45.18 million in revenue each year. Theratechnologies employs 32 workers across the globe.

What is Theratechnologies' official website?

The official website for Theratechnologies is www.theratech.com.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The company can be reached via phone at 514-336-7800 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.